Research graph
References from Dual inhibition of p38α MAPK and Casein kinase δ/ε as a novel treatment strategy for AR-independent and taxane-resistant advanced prostate cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1002/cncr.35833
10.1002/cncr.35833 · External reference
Inhibition of apoptosis in prostate cancer cells by androgens is mediated through downregulation of c-Jun N-terminal kinase activation
10.1593/neo.07985 · 2008 · External reference
10.1001/jama.292.7.821
10.1001/jama.292.7.821 · External reference
10.1038/ncpuro1296
10.1038/ncpuro1296 · External reference
10.1016/j.ccell.2017.09.003
10.1016/j.ccell.2017.09.003 · External reference
Unresolved reference
2014 · External reference
Taxane-based Combination Therapies for Metastatic Prostate Cancer
10.1016/j.euf.2017.11.009 · 2019 · External reference
10.1200/jco.2015.65.7270
10.1200/jco.2015.65.7270 · External reference
10.1371/journal.pone.0139440
10.1371/journal.pone.0139440 · External reference
Progression of metastatic castrate-resistant prostate cancer: Impact of therapeutic intervention in the post-docetaxel space
2011 · External reference
Treatment options in castration-resistant prostate cancer: Current therapies and emerging docetaxel-based regimens
10.1016/j.urolonc.2013.01.005 · 2014 · External reference
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet (London
2010 · External reference
10.3390/ijms18122574
10.3390/ijms18122574 · External reference
10.1101/2022.07.20.500378
10.1101/2022.07.20.500378 · External reference
10.1038/s41408-022-00636-2
10.1038/s41408-022-00636-2 · External reference
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations
10.1016/j.cels.2017.11.001 · 2018 · External reference
10.1083/jcb.201902057
10.1083/jcb.201902057 · External reference
ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia (New York
2004 · External reference
10.1016/j.cell.2015.10.025
10.1016/j.cell.2015.10.025 · External reference
10.1016/j.cell.2017.06.010
10.1016/j.cell.2017.06.010 · External reference
Side population: ITs use in the study of cellular heterogeneity and as a potential enrichment tool for rare cell populations
2018 · External reference
Cancer stem cells in prostate cancer
2013 · External reference
Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach
2018 · External reference
10.1016/j.ajur.2018.11.005
10.1016/j.ajur.2018.11.005 · External reference
10.1021/jm050165o
10.1021/jm050165o · External reference
Role of p38 MAP Kinase Signal Transduction in Solid Tumors
10.1177/1947601913507951 · 2013 · External reference
10.1016/j.bbrc.2006.12.077
10.1016/j.bbrc.2006.12.077 · External reference
Pyrimethamine Elicits Antitumor Effects on Prostate Cancer by Inhibiting the p38-NF-κB Pathway
2020 · External reference
10.3390/cancers13010023
10.3390/cancers13010023 · External reference
10.1371/journal.pone.0002355
10.1371/journal.pone.0002355 · External reference
10.1002/pros.21331
10.1002/pros.21331 · External reference
10.3390/cancers12061663
10.3390/cancers12061663 · External reference
10.1016/j.chembiol.2011.01.015
10.1016/j.chembiol.2011.01.015 · External reference
Wnt signaling in castration-resistant prostate cancer: implications for therapy
2014 · External reference
Hes1: a key role in stemness, metastasis and multidrug resistance
10.1080/15384047.2015.1016662 · 2015 · External reference
Hes1 is involved in the self-renewal and tumourigenicity of stem-like cancer cells in colon cancer
10.1038/srep03963 · 2014 · External reference
10.1186/s12943-018-0794-0
10.1186/s12943-018-0794-0 · External reference
10.1158/1078-0432.ccr-18-3410
10.1158/1078-0432.ccr-18-3410 · External reference
Targeting Splicing in Prostate Cancer
10.3390/ijms19051287 · 2018 · External reference
10.1158/1535-7163.mct-06-0727
10.1158/1535-7163.mct-06-0727 · External reference
10.1038/cddis.2017.405
10.1038/cddis.2017.405 · External reference
10.3390/cells10030634
10.3390/cells10030634 · External reference
10.1158/0008-5472.can-18-4099
10.1158/0008-5472.can-18-4099 · External reference
Nuclear transcription factor Nrf2 suppresses prostate cancer cells growth and migration through upregulating ferroportin
10.18632/oncotarget.12860 · 2016 · External reference
10.1111/j.1582-4934.2012.01612.x
10.1111/j.1582-4934.2012.01612.x · External reference
10.1016/j.pbiomolbio.2021.05.002
10.1016/j.pbiomolbio.2021.05.002 · External reference
10.1074/jbc.m111.323709
10.1074/jbc.m111.323709 · External reference
10.3389/fimmu.2022.1052768
10.3389/fimmu.2022.1052768 · External reference
Single-Cell and Bulk RNA Sequencing Highlights Intra-Tumoral Heterogeneity and Malignant Progression Mechanisms in Prostate Cancer
10.1111/jcmm.70806 · 2025 · External reference
10.1007/s12672-022-00469-2
10.1007/s12672-022-00469-2 · External reference
Elevated Expression of NOP16 as a Novel Prognostic Biomarker of Prostate Cancer
2023 · External reference
10.1007/s12032-024-02580-6
10.1007/s12032-024-02580-6 · External reference
RAD21 promotes oncogenesis and lethal progression of prostate cancer
10.1073/pnas.2405543121 · 2024 · External reference
Myc family proteins: Molecular drivers of tumorigenesis and resistance in neuroendocrine tumors
10.1016/j.bbcan.2025.189332 · 2025 · External reference
10.3390/biology14030256
10.3390/biology14030256 · External reference
10.1158/0008-5472.can-19-0458
10.1158/0008-5472.can-19-0458 · External reference
10.1096/fj.202000101rr
10.1096/fj.202000101rr · External reference
10.1093/nar/gks1111
10.1093/nar/gks1111 · External reference
10.1158/0008-5472.can-09-1947
10.1158/0008-5472.can-09-1947 · External reference
10.3390/mi15060720
10.3390/mi15060720 · External reference
10.1073/pnas.0506580102
10.1073/pnas.0506580102 · External reference
Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics (Oxford
2014 · External reference
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia (New York
2017 · External reference
10.3389/fonc.2020.00068
10.3389/fonc.2020.00068 · External reference
10.1158/0008-5472.can-13-2699
10.1158/0008-5472.can-13-2699 · External reference
